GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation

Journal of Immunology

Volumn 187, Issue 3, 2011, Pages 1254-1263

  Curran, Colleen S ^a   Evans, Michael D ^b   Bertics, Paul J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; CD11B ANTIGEN; CD69 ANTIGEN; DEXAMETHASONE; EOSINOPHIL PEROXIDASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; EOSINOPHIL; GLIOBLASTOMA; GLIOBLASTOMA CELL; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; EOSINOPHILS; GLIOBLASTOMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; PARACRINE COMMUNICATION; UP-REGULATION;

EID: 80051617751     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001965     Document Type: Article

References (74)

1. Giembycz, M. A., and M. A. Lindsay. 1999. Pharmacology of the eosinophil. Pharmacol. Rev. 51: 213-340.
2. Charcot, J. M., and C. Robin. 1853. Observation de Leucocythemie. C. R. Mem. Soc. Biol. 5: 44.
3. Leyden, E. 1872. Zur Kenntniss des bronchial asthma. Virchows Arch. Pathol. Anat. 54: 324-344.
4. Lowe, D., J. Jorizzo, and M. S. Hutt. 1981. Tumour-associated eosinophilia: a review. J. Clin. Pathol. 34: 1343-1348. (Pubitemid 12168683)
5. Samoszuk, M. 1997. Eosinophils and human cancer. Histol. Histopathol. 12: 807-812. (Pubitemid 27314712)
6. Denburg, J. A., and P. K. Keith. 2008. Eosinophil progenitors in airway diseases: clinical implications. Chest 134: 1037-1043.
7. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454: 436-444.
8. Pandit, R., A. Scholnik, L. Wulfekuhler, and N. Dimitrov. 2007. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am. J. Hematol. 82: 234-237. (Pubitemid 46363793)
9. Jensen-Jarolim, E., G. Achatz, M. C. Turner, S. Karagiannis, F. Legrand, M. Capron, M. L. Penichet, J. A. Rodríguez, A. G. Siccardi, L. Vangelista, et al. 2008. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63: 1255-1266.
10. Lotfi, R., J. J. Lee, and M. T. Lotze. 2007. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J. Immunother. 30: 16-28. (Pubitemid 46052200)
11. Trivedi, S. G., and C. M. Lloyd. 2007. Eosinophils in the pathogenesis of allergic airways disease. Cell. Mol. Life Sci. 64: 1269-1289. (Pubitemid 46791053)
12. Wiemels, J. L., J. K. Wiencke, J. D. Sison, R. Miike, A. McMillan, and M. Wrensch. 2002. History of allergies among adults with glioma and controls. Int. J. Cancer 98: 609-615. (Pubitemid 34208564)
13. Wiemels, J. L., J. K. Wiencke, J. Patoka, M. Moghadassi, T. Chew, A. McMillan, R. Miike, G. Barger, and M. Wrensch. 2004. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res. 64: 8468-8473. (Pubitemid 39491789)
14. Linos, E., T. Raine, A. Alonso, and D. Michaud. 2007. Atopy and risk of brain tumors: a meta-analysis. J. Natl. Cancer Inst. 99: 1544-1550. (Pubitemid 351767237)
15. Wigertz, A., S. Lönn, J. Schwartzbaum, P. Hall, A. Auvinen, H. C. Christensen, C. Johansen, L. Klaeboe, T. Salminen, M. J. Schoemaker, et al. 2007. Allergic conditions and brain tumor risk. Am. J. Epidemiol. 166: 941-950. (Pubitemid 47511691)
16. Reardon, D. A., and P. Y. Wen. 2006. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.Oncologist 11: 152-164. (Pubitemid 43261762)
17. Gomez, G. G., and C. A. Kruse. 2006. Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther. Mol. Biol. 10(A): 133-146.
18. Hayes, R. L., M. Koslow, E. M. Hiesiger, K. B. Hymes, H. S. Hochster, E. J. Moore, D. M. Pierz, D. K. Chen, G. N. Budzilovich, and J. Ransohoff. 1995. Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma. Cancer 76: 840-852.
19. Hayes, R. L., E. Arbit, M. Odaimi, S. Pannullo, R. Scheff, D. Kravchinskiy, and C. Zaroulis. 2001. Adoptive cellular immunotherapy for the treatment of malignant gliomas. Crit. Rev. Oncol. Hematol. 39: 31-42. (Pubitemid 32551987)
20. Yu, J. S., M. X. Wei, E. A. Chiocca, R. L. Martuza, and R. I. Tepper. 1993. Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res. 53: 3125-3128. (Pubitemid 23210323)
21. Tseng, S. H., L. H. Hwang, and S. M. Lin. 1997. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines. J. Immunother. 20: 334-342.
22. Herrlinger, U., C. M. Kramm, K. M. Johnston, D. N. Louis, D. Finkelstein, G. Reznikoff, G. Dranoff, X. O. Breakefield, and J. S. Yu. 1997. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Ther. 4: 345-352. (Pubitemid 127667126)
23. Golden, J., D. M. Frim, P. H. Chapman, and J. P. Vonsattel. 1994. Marked tissue eosinophilia within organizing chronic subdural hematoma membranes. Clin. Neuropathol. 13: 12-16. (Pubitemid 24035723)
24. Cormier, S. A., A. G. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. I. Ochkur, K. O'Neill, D. Colbert, et al. 2006. Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J. Leukoc. Biol. 79: 1131-1139. (Pubitemid 44835546)
25. Muggia, F. M., N. A. Ghossein, and H. Wohl. 1973. Eosinophilia following radiation therapy. Oncology 27: 118-127.
26. Lee, E. L., and T. S. Armstrong. 2008. Increased intracranial pressure. Clin. J. Oncol. Nurs. 12: 37-41.
27. Lampinen, M., M. Carlson, L. D. Håkansson, and P. Venge. 2004. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59: 793-805. (Pubitemid 39005818)
28. Strath, M., D. J. Warren, and C. J. Sanderson. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods 83: 209-215. (Pubitemid 16225442)
29. Nagata, M., H. Yamamoto, M. Shibasaki, Y. Sakamoto, and H. Matsuo. 2000. Hydrogen peroxide augments eosinophil adhesion via beta2 integrin. Immunology 101: 412-418.
30. Bates, M. E., J. B. Sedgwick, Y. Zhu, L. Y. Liu, R. G. Heuser, N. N. Jarjour, H. Kita, and P. J. Bertics. 2010. Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils. J. Immunol. 184: 7125-7133.
31. Kuang, D. M., Y. Wu, N. Chen, J. Cheng, S. M. Zhuang, and L. Zheng. 2007. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110: 587-595. (Pubitemid 47105397)
32. Conboy, I. M., R. H. DeKruyff, K. M. Tate, Z. A. Cao, T. A. Moore, D. T. Umetsu, and P. P. Jones. 1997. Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains. J. Exp. Med. 185: 439-451. (Pubitemid 27078362)
33. Chavakis, T., A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, and P. P. Nawroth. 2003. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198: 1507-1515. (Pubitemid 37467165)
34. Ishiguro, H., N. Nakaigawa, Y. Miyoshi, K. Fujinami, Y. Kubota, and H. Uemura. 2005. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 64: 92-100. (Pubitemid 40734743)
35. Bartling, B., H. S. Hofmann, B. Weigle, R. E. Silber, and A. Simm. 2005. Downregulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26: 293-301. (Pubitemid 40246550)
36. Khaitan, D., S. Chandna, M. B. Arya, and B. S. Dwarakanath. 2006. Establishment and characterization of multicellular spheroids from a human glioma cell line; implications for tumor therapy. J. Transl. Med. 4: 12.
37. Desoize, B., and J. Jardillier. 2000. Multicellular resistance: a paradigm for clinical resistance? Crit. Rev. Oncol. Hematol. 36: 193-207.
38. Gottfried, E., L. A. Kunz-Schughart, R. Andreesen, and M. Kreutz. 2006. Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions. Cell Cycle 5: 691-695.
39. Ciembroniewicz, J., and O. Kolar. 1967. Eosinophilic response in glioblastoma tissue culture after addition of autologous lymphocytes. Science 157: 1054-1055.
40. in 't Veen, J. C., D. C. Grootendorst, E. H. Bel, H. H. Smits, M. Van Der Keur, P. J. Sterk, and P. S. Hiemstra. 1998. CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects. Clin. Exp. Allergy 28: 606-615. (Pubitemid 28238276)
41. Kelly, E. A., C. J. Koziol-White, K. J. Clay, L. Y. Liu, M. E. Bates, P. J. Bertics, and N. N. Jarjour. 2009. Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma. J. Immunol. 182: 1404-1410.
42. Uings, I., I. Puxeddu, V. Temkin, S. J. Smith, D. Fattah, K. P. Ray, and F. Levi-Schaffer. 2005. Effects of dexamethasone on TNF-alpha-induced release of cytokines from purified human blood eosinophils. Clin. Mol. Allergy 3: 5.
43. Kobayashi, T., H. Kouzaki, and H. Kita. 2010. Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J. Immunol. 184: 6350-6358.
44. Ziegler, S. F., F. Ramsdell, and M. R. Alderson. 1994. The activation antigen CD69. Stem Cells 12: 456-465. (Pubitemid 24278225)
45. Frei, K., D. Piani, U. V. Malipiero, E. Van Meir, N. de Tribolet, and A. Fontana. 1992. Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J. Immunol. 148: 3140-3146.
46. Manitz, M. P., B. Horst, S. Seeliger, A. Strey, B. V. Skryabin, M. Gunzer, W. Frings, F. Schönlau, J. Roth, C. Sorg, and W. Nacken. 2003. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 23: 1034-1043. (Pubitemid 36133519)
47. Salama, I., P. S. Malone, F. Mihaimeed, and J. L. Jones. 2008. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34: 357-364. (Pubitemid 351381290)
48. Ghavami, S., S. Chitayat, M. Hashemi, M. Eshraghi, W. J. Chazin, A. J. Halayko, and C. Kerkhoff. 2009. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur. J. Pharmacol. 625: 73-83.
49. Ito, A., M. Miyake, M. Morishita, K. Ito, S. Torii, and T. Sakamoto. 2003. Dexamethasone reduces lung eosinophilia, and VCAM-1 and ICAM-1 expression induced by Sephadex beads in rats. Eur. J. Pharmacol. 468: 59-66. (Pubitemid 36555752)
50. McClelland, S., III, and D. M. Long. 2008. Genesis of the use of corticosteroids in the treatment and prevention of brain edema. Neurosurgery 62: 965-967, discussion 967-968.
51. Bergmann, M. W., K. J. Staples, S. J. Smith, P. J. Barnes, and R. Newton. 2004. Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. Am. J. Respir. Cell Mol. Biol. 30: 555-563. (Pubitemid 38457188)
52. Puxeddu, I., A. Alian, A. M. Piliponsky, D. Ribatti, A. Panet, and F. Levi- Schaffer. 2005. Human peripheral blood eosinophils induce angiogenesis. Int. J. Biochem. Cell Biol. 37: 628-636. (Pubitemid 40022939)
53. Anceriz, N., K. Vandal, and P. A. Tessier. 2007. S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. Biochem. Biophys. Res. Commun. 354: 84-89. (Pubitemid 46123204)
54. Zámecník, J., L. Vargová, A. Homola, R. Kodet, and E. Syková. 2004. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol. Appl. Neurobiol. 30: 338-350. (Pubitemid 39120295)
55. Chen, T. C., D. R. Hinton, M. L. Apuzzo, and F. M. Hofman. 1993. Differential effects of tumor necrosis factor-alpha on proliferation, cell surface antigen expression, and cytokine interactions in malignant gliomas. Neurosurgery 32: 85-94. (Pubitemid 23020002)
56. Mueller, M. M., C. C. Herold-Mende, D. Riede, M. Lange, H. H. Steiner, and N. E. Fusenig. 1999. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am. J. Pathol. 155: 1557-1567.
57. Langeveld, C. H., M. P. van Waas, J. C. Stoof, W. Sutanto, E. R. de Kloet, J. G. Wolbers, and J. J. Heimans. 1992. Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. J. Neurosci. Res. 31: 524-531.
58. Nestler, U., M. Winking, and D. K. Böker. 2002. The tissue level of dexamethasone in human brain tumors is about 1000 times lower than the cytotoxic concentration in cell culture. Neurol. Res. 24: 479-482. (Pubitemid 34742682)
59. Druilhe, A., Z. Cai, S. Hailé, S. Chouaib, and M. Pretolani. 1996. Fas-mediated apoptosis in cultured human eosinophils. Blood 87: 2822-2830. (Pubitemid 26102232)
60. Roessler, K., G. Suchanek, H. Breitschopf, K. Kitz, C. Matula, H. Lassmann, and W. T. Koos. 1995. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. J. Neurosurg. 83: 291-297.
61. Goh, J. J., S. J. See, E. Ang, and W. H. Ng. 2009. Vanishing glioblastoma after corticosteroid therapy. J. Clin. Neurosci. 16: 1226-1228.
62. Hasegawa, H., D. Pal, R. Ramirez, A. Ismail, and P. Marks. 2009. Glioblastoma multiforme fades on CT imaging after dexamethasone therapy. J. Clin. Neurosci. 16: 1707-1708.
63. Gu, Y. T., L. J. Qin, X. Qin, and F. Xu. 2009. The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model. Neurosci. Lett. 452: 114-118.
64. Walz, T. M., B. K. Nishikawa, C. Malm, K. Briheim, and A. Wasteson. 1994. Transforming growth factor alpha expression in normal human blood eosinophils: differential regulation by granulocyte-macrophage colony-stimulating factor and interleukin-3. Leukemia 8: 612-619. (Pubitemid 24133028)
65. Matsumoto, K., S. Fukuda, Y. Nakamura, and H. Saito. 2009. Amphiregulin production by human eosinophils. Int. Arch. Allergy Immunol. 149(Suppl. 1): 39-44.
66. Zandi, R., A. B. Larsen, P. Andersen, M. T. Stockhausen, and H. S. Poulsen. 2007. Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell. Signal. 19: 2013-2023. (Pubitemid 47353811)
67. Gan, H. K., A. H. Kaye, and R. B. Luwor. 2009. The EGFRvIII variant in glioblastoma multiforme. J. Clin. Neurosci. 16: 748-754.
68. Deininger, M. H., S. Pater, H. Strik, and R. Meyermann. 2001. Macrophage/ microglial cell subpopulations in glioblastoma multiforme relapses are differentially altered by radiochemotherapy. J. Neurooncol. 55: 141-147. (Pubitemid 34134037)
69. Yamahara, T., Y. Numa, T. Oishi, T. Kawaguchi, T. Seno, A. Asai, and K. Kawamoto. 2010. Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging. Brain Tumor Pathol. 27: 81-87.
70. Li, J. J., D. Dickson, P. R. Hof, and H. Vlassara. 1998. Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis. Mol. Med. 4: 46-60. (Pubitemid 28134332)
71. Trutmann, M., L. Terracciano, C. Noppen, J. Kloth, M. Kaspar, R. Peterli, P. Tondelli, C. Schaeffer, P. Zajac, M. Heberer, and G. C. Spagnoli. 1998. GMCSF gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens. Int. J. Cancer 77: 378-385. (Pubitemid 28299873)
72. Lang, S. H., W. R. Miller, W. Duncan, and F. K. Habib. 1994. Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer 59: 235-241. (Pubitemid 24343368)
73. Bennicelli, J. L., and D. Guerry IV. 1993. Production of multiple cytokines by cultured human melanomas. Exp. Dermatol. 2: 186-190. (Pubitemid 24009476)
74. Luna-Moré, S., P. Florez, A. Ayala, F. Diaz, and A. Santos. 1997. Neutral and acid mucins and eosinophil and argyrophil crystalloids in carcinoma and atypical adenomatous hyperplasia of the prostate. Pathol. Res. Pract. 193: 291-298. (Pubitemid 27399703)